Understanding how cell communication affects glaucoma progression
CXCR3-Mediated Cell-Cell Communication in Glaucoma
This study is looking at how certain signals in the eye might contribute to glaucoma, which can cause vision loss, and it hopes to find new ways to treat the condition beyond just lowering eye pressure, so that patients can have better options for preserving their sight.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-10896322 on NIH RePORTER |
What this research studies
This research investigates the role of CXCR3-mediated cell communication in glaucoma, a condition that leads to irreversible blindness due to the death of retinal ganglion cells. The study aims to explore how chemokines, particularly CXCL10, interact with their receptors to influence inflammation and neurodegeneration in the retina. By examining these mechanisms, the research seeks to identify new therapeutic targets beyond just lowering intraocular pressure, which is currently the only treatment available. Patients may benefit from insights that could lead to innovative treatments for glaucoma.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with glaucoma, particularly those experiencing progressive vision loss despite treatment.
Not a fit: Patients with glaucoma who are not experiencing disease progression or those with other unrelated eye conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that prevent or slow down the progression of glaucoma, potentially preserving vision for many patients.
How similar studies have performed: While the role of chemokines in other diseases has been studied, the specific investigation of CXCR3-mediated communication in glaucoma is relatively novel and untested.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Zhang, Wenbo — University of Texas Med Br Galveston
- Study coordinator: Zhang, Wenbo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.